Anne-Vincent Salomon

57PUBLICATIONS
335CO-AUTHORS
Tumour immunologyCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|May 12, 2026
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

|Dec 10, 2025
A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription.

Anna Minello, Jesus Gomez-Escudero, Sreerama Chaitanya Sridhara

|Nov 12, 2025
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation.

Isabella Hofer, Yann Kieffer, Arianna Mencattini

|Oct 09, 2025
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.

Nouritza Torossian, Marc Gabriel, Panagiotis Papoutsoglou

|Aug 22, 2025
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

François-Clément Bidard, Grégoire Gessain, Thomas Bachelot

|Jul 02, 2025
Author Correction: Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes.

André Bortolini Silveira, Alexandre Houy, Olivier Ganier

Pageof 10

Frequent Collaborators

9 joint publications

Fatima Mechta-Grigoriou

9 joint publications

François-Clément Bidard

8 joint publications

Marc-Henri Stern

7 joint publications

Sylvain Baulande